Health
Cleavage site recognition by SARS-CoV-2 main protease as new antiviral drug target – News-Medical.Net
Many research groups have and are investigating main protease inhibitors as antiviral drugs, and in a paper recently uploaded to the bioRxiv* preprint server, a…
The main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cleaves the proteins produced by the virus at various stages of replication and maturation. Highly conserved across coronaviruses due to the essential functional role of the enzyme, it also makes an appealing drug target.
Many research groups have and are investigating main protease inhibitors as antiviral drugs, and in a paper recently uploaded to the bioRxiv* preprint server, a team of researchers examine the crystal…
-
General23 hours agoLambie, hypocrisy, and the misinformation & disinformation bill
-
General22 hours agoAFLW Sunday: Chloe Molloy kicks wonder goal as Zippy Fish stars for Swans
-
General23 hours agoDockers coach Justin Longmuir calls for AFL to issue huge fines over staging
-
General20 hours agoJim Chalmers’ socialist séance might be over